[1]
“Pathological response and efficacy of neoadjuvant carboplatine in early triple negative breast cancer”, Tuj-hlth, vol. 43, no. 5, Oct. 2021, Accessed: Nov. 01, 2026. Available: https://journal.latakia-univ.edu.sy/index.php/hlthscnc/article/view/11004